Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00302198 · ClinicalTrials.gov registry record

Amyotrophic Lateral Sclerosis Web Based Patient Care Database: ALSConnection.Org

A clinical trial of Amyotrophic Lateral Sclerosis, sponsored by Forbes Norris MDA/ALS Research Center.

Completed
Registry status
15,000
Enrollment target
1
Study location

NCT00302198 is a study of Amyotrophic Lateral Sclerosis that has completed, run by Forbes Norris MDA/ALS Research Center. The registered enrollment target is 15,000 participants, above the 751-participant average among 102 other Amyotrophic Lateral Sclerosis trials with a reported enrollment target (1897% higher). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00302198, a study of Amyotrophic Lateral Sclerosis, has completed, sponsored by Forbes Norris MDA/ALS Research Center.

COMPLETED
Registry status
15,000 participants
Enrollment target
1
Study location

Study Summary

The purpose is to collect data for ALS research. The data will be used to learn more about the origin of ALS and to improve quality of care for people with ALS. The information you provide in the ALS registry will be used to evaluate variations in patient care, adherence to standards of care and also to help foster ALS research.

Interventions

  • BEHAVIORAL ALS Registry

Study Locations (1)

California

  • Forbes Norris MDA/ALS Center - San Francisco

Trial Details

FieldValue
Enrollment Target 15,000 participants
Start Date 2006-01
Est. Completion 2010-02

What the Registry Record Tells You About NCT00302198

The ClinicalTrials.gov registry entry for NCT00302198 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 15,000 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 751-participant average among 102 other Amyotrophic Lateral Sclerosis trials with a reported enrollment target (1897% higher). The listed sponsor is Forbes Norris MDA/ALS Research Center, which has 2 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Amyotrophic Lateral Sclerosis appearing as the primary indexed condition, and to 1 intervention - of which ALS Registry is the first listed.

NCT00302198 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT00302198 about?

NCT00302198 is a clinical study titled "Amyotrophic Lateral Sclerosis Web Based Patient Care Database: ALSConnection.Org". The purpose is to collect data for ALS research. The data will be used to learn more about the origin of ALS and to improve quality of care for people with ALS. The information you provide in the ALS registry will be used to evaluate variations in patient care, adherence to standards of care and als...

What is the current status of trial NCT00302198?

This trial is currently completed. The enrollment target is 15,000 participants. The study started on 2006-01. Estimated completion is 2010-02.

What conditions does trial NCT00302198 study?

This clinical trial studies the following conditions: Amyotrophic Lateral Sclerosis.

What interventions are being tested in trial NCT00302198?

The interventions under investigation include: ALS Registry (BEHAVIORAL).

Who is sponsoring clinical trial NCT00302198?

This trial is sponsored by Forbes Norris MDA/ALS Research Center, which has 2 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00302198 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Amyotrophic Lateral Sclerosis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.